Also written by Reuters:
Coca-Cola Faces Renewed Pressure Over Executive Pay
x hide permanently

Pershing Square, Valeant Arrive at Settlement Split for Allergan Lawsuit

Read (Reuters) - Activist investor William Ackman’s Pershing Square PHS.AS and Valeant Pharmaceuticals ( VRX.TO ) on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc ...

Mentions: Management lawsuit Valeant Pharmaceuticals